Subcommittee on Neurological Disease committee  Regarding costs, I have conducted a financial analysis to compare the costs of medications for multiple sclerosis with what the costs would be for this procedure. What we found was that if it basically halts the progression for even 20% of the people with MS, Canada would save m

Subcommittee on Neurological Disease committee  One of the things I would like to say is that people often say if we start testing and treating MS patients right now, it will take away from doing clinical trials. This is totally false. First of all, trials are usually very small, 100 to 200 people, so what happens to the rest

Subcommittee on Neurological Disease committee  Canada gave the world insulin, mobile blood transfusion, and the Montreal procedure, a surgical treatment for epilepsy. Back then, the barriers were the frontiers of medicine. Today they're between the specialities of medicine. We are up against myths and self-serving practices.

Subcommittee on Neurological Disease committee  No, I'm not.